Semnur Pharmaceuticals, Inc. reports

Company Who this page is about. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field
Fiscal year end
31 December
Semnur Pharmaceuticals, Inc. has filed 210 SEC EDGAR filings since 01 Mar 2022

SEC filing history

Showing 1-13 of 13 matching filings.

Per page
25
Current page
1
10-Q File 001-41351

QUARTERLY REPORT

Filing date
15 Aug 2025
Reporting date
30 Jun 2025
Next action
Verify source filing
10-Q File 001-41351

QUARTERLY REPORT

Filing date
16 May 2025
Reporting date
31 Mar 2025
Next action
Verify source filing
10-Q File 001-41351

QUARTERLY REPORT

Filing date
19 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
10-Q File 001-41351

QUARTERLY REPORT

Filing date
19 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
10-Q File 001-41351

QUARTERLY REPORT

Filing date
22 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
10-Q File 001-41351

QUARTERLY REPORT

Filing date
09 Nov 2023
Reporting date
30 Sep 2023
Next action
Verify source filing
10-Q File 001-41351

QUARTERLY REPORT

Filing date
15 Aug 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .